CAG trinucleotide RNA repeats interact with RNA-binding proteins. McLaughlin BA, Spencer C, Eberwine J (1996) Am J Hum Genet 59: 561-9 No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls. Montine TJ, Shinobu L, Montine KS, Roberts LJ, Kowall NW, Beal MF, Morrow JD (2000) Ann Neurol 48: 950 Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice. Pancani T, Foster DJ, Moehle MS, Bichell TJ, Bradley E, Bridges TM, Klar R, Poslusney M, Rook JM, Daniels JS, Niswender CM, Jones CK, Wood MR, Bowman AB, Lindsley CW, Xiang Z, Conn PJ (2015) Proc Natl Acad Sci U S A 112: 14078-83 Manganese Is Essential for Neuronal Health. Horning KJ, Caito SW, Tipps KG, Bowman AB, Aschner M (2015) Annu Rev Nutr 35: 71-108 Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Montine TJ, Beal MF, Robertson D, Cudkowicz ME, Biaggioni I, O'Donnell H, Zackert WE, Roberts LJ, Morrow JD (1999) Neurology 52: 1104-5 A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease. Tidball AM, Bryan MR, Uhouse MA, Kumar KK, Aboud AA, Feist JE, Ess KC, Neely MD, Aschner M, Bowman AB (2015) Hum Mol Genet 24: 1929-44 Genetic modifiers of neurological disease. Kearney JA (2011) Curr Opin Genet Dev 21: 349-53 Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model. Bichell TJV, Wegrzynowicz M, Tipps KG, Bradley EM, Uhouse MA, Bryan M, Horning K, Fisher N, Dudek K, Halbesma T, Umashanker P, Stubbs AD, Holt HK, Kwakye GF, Tidball AM, Colbran RJ, Aschner M, Neely MD, Di Pardo A, Maglione V, Osmand A, Bowman AB (2017) Biochim Biophys Acta Mol Basis Dis 1863: 1596-1604 Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. Kumar KK, Goodwin CR, Uhouse MA, Bornhorst J, Schwerdtle T, Aschner M, McLean JA, Bowman AB (2015) Metallomics 7: 363-70 Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure. Williams BB, Li D, Wegrzynowicz M, Vadodaria BK, Anderson JG, Kwakye GF, Aschner M, Erikson KM, Bowman AB (2010) J Neurochem 112: 227-37 iNKT Cell Activation Exacerbates the Development of Huntington's Disease in R6/2 Transgenic Mice. Park HJ, Lee SW, Im W, Kim M, Van Kaer L, Hong S (2019) Mediators Inflamm 2019: 3540974 Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells. Tidball AM, Neely MD, Chamberlin R, Aboud AA, Kumar KK, Han B, Bryan MR, Aschner M, Ess KC, Bowman AB (2016) PLoS One 11: e0150372 Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. Madison JL, Wegrzynowicz M, Aschner M, Bowman AB (2012) PLoS One 7: e31024 Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease. Di Pardo A, Amico E, Basit A, Armirotti A, Joshi P, Neely MD, Vuono R, Castaldo S, Digilio AF, Scalabrì F, Pepe G, Elifani F, Madonna M, Jeong SK, Park BM, D'Esposito M, Bowman AB, Barker RA, Maglione V (2017) Sci Rep 7: 5280 Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington's disease confirms a deficit in manganese accumulation. Kwakye GF, Li D, Bowman AB (2011) Neurotoxicology 32: 630-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.